A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease
Clinical trial NCT02353598 · COMPLETED
Trial details
- NCT number
- NCT02353598
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-26
- Primary completion
- 2016-11-30
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.